空洞型球孢子菌病的专家管理意见
球孢子菌病由粗球孢子菌和波萨达斯球孢子菌引起,约30%暴露者出现原发性肺球孢子菌病,5%出现严重或播散性病变,5%至15%的肺球孢子菌病患者可遗留结节、脓肿或空洞性病变。现有文献和实践指南缺乏清晰的空洞型球孢子菌病管理策略,本报告由多学科专家组提出评估与管理建议。
要点
- 约5%至15%的肺球孢子菌病患者可出现结节、脓肿或空洞性病变等长期肺部后遗症。
- 空洞性病变需与恶性肿瘤及其他感染如结核鉴别。
- 现有指南缺乏清晰管理策略,本建议来自多学科专家组。
核心结论
- 空洞型球孢子菌病可造成长期肺部后遗症并给患者和医疗系统带来沉重负担,但现有文献和实践指南缺乏清晰管理策略。
- 本报告由多学科专家组提出针对空洞型球孢子菌病各种形式、表现和并发症的评估与管理建议。
研究设计与样本
- 本文为专家意见报告,建议由多学科专家组制定。
主要发现
- 约30%暴露于空气中球孢子菌的人会出现原发性肺球孢子菌病,症状类似社区获得性肺炎或其他呼吸系统疾病。
- 5%的肺球孢子菌病患者会出现严重甚至危及生命的表现,包括肺外或播散性球孢子菌病。
- 既往证据提示约5%至15%的肺球孢子菌病患者会出现结节、脓肿或空洞性病变等长期肺部后遗症。
临床怎么用
- 对肺球孢子菌病患者的结节、脓肿或空洞性病变,需与恶性肿瘤及其他感染如结核进行鉴别。
局限性
- 当前文献综述和实践指南缺乏清晰的空洞型球孢子菌病管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coccidioidomycosis, caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii, is recognized as an increasing threat both nationally and worldwide. This is in large part secondary to the expanding range of Coccidioides species and increased international travel to endemic regions. Most individuals exposed to airborne Coccidioides organisms do not need medical attention, but approximately 30% will demonstrate primary pulmonary coccidioidomycosis with signs and symptoms that mimic community-acquired pneumonia or other respiratory illnesses. Further, 5% of those with a diagnosis of pulmonary coccidioidomycosis will demonstrate serious and even life-threatening manifestations, including extrapulmonary or disseminated coccidioidomycosis. Of those who demonstrate pulmonary coccidioidomycosis, past evidence suggests that approximately 5% to 15% will experience long-term pulmonary sequelae in the form of nodules, abscesses, or cavitary lesions. These lesions may not be easily distinguished from malignancy or other infections, such as TB, and they add a substantial burden to both patients and the health care system. Despite the long-term consequences of cavitary coccidioidomycosis in some individuals, the current literature review and practice guidelines demonstrate a paucity of clear management strategies to treat these patients. In this report, we focus on cavitary lesions in coccidioidomycosis with the goal of presenting a description of the evaluation and management of their various forms, manifestations, and complications. These recommendations are derived from a multidisciplinary group of experts.
引用
- Donovan FM, Thompson GR, Blair JE, et al. Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes. Chest. 2024. PMID: 39675520. doi:10.1016/j.chest.2024.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。